Committed to making a difference for:


500,000 people in the U.S. – and three times that many globally – are on the organ waitlist and dialysis


Provide better instruments and ex vivo organ metrics with which to work and make critical, life-saving decisions


Last year nearly 30% of donated kidneys were not transplanted, and only 10% of the transplant need is accommodated globally


Transplants have the potential to bend down the cost curve since they are less expensive than dialysis

Our Partners

Duquesne University
School of Pharmacy
Duke University
ExVivo Organ Lab (“DEVOL”)
RegenMed Development Organization (ReMDO)
Atrium Health,
Wake Forest Institute of Regenerative Medicine (“WFIRM”)
Department of Defense
Armed Forces Institute for Regenerative Medicine (AFRIM)
UNC Kidney Center
US National Lab
Department of Energy
Department of Neuroscience, Yale School Of Medicine, Sestan Lab
BMI is an NCBC portfolio company